HK2 and oral cavity squamous cell carcinoma: Tanshinone IIA inhibits the development and proliferation of oral squamous cell carcinoma cells by suppressing Akt-c-Myc signaling and HK2-mediated glycolysis by diminishing HK2 expression at the transcriptional level [165].